AnalystRadar
HAE Updated Aug 13, 2026

Haemonetics Corporation (HAE)

Analyst consensus, price target and coverage. 10 analysts, updated daily.

Consensus Buy= Unchanged
Price 91.34 USD
Mean target 96.20 USD
Upside +5.3% target vs price
Market cap Mid 4.2B

Analyst votes

How the ratings break down

11 ratings on record

Price targets

Where the estimates sit

How far apart analysts are on this name.

Low 86.00 Mean 96.20 High 105.00

share price 91.34 mean target 96.20. Analysts are spread 22% apart.

Most recent action

Last rating change

FirmCitigroup
Date2026-08-07
ChangeNeutral → Neutral

Size and liquidity

Key statistics

Market cap4.16B USD
Cap classMid
Average volume863,012
Dollar volume per day78.8M
LiquidityHigh
Internal score62.5 / 100

Recommendation

How it moved, scan by scan

2 scans on record

ScanMoveConsensusScoreSBBuyHoldUndSell
2026-08-13 = Buy 1.91 4 4 3 0 0
2026-08-11 · Buy 1.91 4 4 3 0 0

Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. more positive, more negative, = unchanged.

History

Price target over time

2 daily points recorded

DatePriceTargetUpsideConsensus
2026-08-13 91.34 96.20 +5.3% Buy
2026-08-11 87.21 96.20 +10.3% Buy

Similar coverage

Comparable mid-cap names

Closest upside among companies of the same size.

← All 1035 companies in the screener